Bartonella henselae encephalopathy in a paediatric patient: A case report and treatment review

Ana Peláez Bejarano1, Raquel Sánchez Del Moral1, Ana Belen Guisado-Gil1

  • 1Unidad de Gestión Clínica Farmacia, Hospital Juan Ramón Jiménez, Huelva, Spain.

Insights

Atypical cat scratch disease (CSD) in a child presented with neurological symptoms. Targeted antibiotic therapy with azithromycin and rifampin led to recovery, highlighting effective treatment options for pediatric CSD.

Area of Science:

  • Infectious Diseases
  • Pediatric Neurology

Background:

  • Bartonella henselae causes cat scratch disease (CSD).
  • Atypical CSD presentations, particularly neurological manifestations in children, require specific diagnostic and therapeutic approaches.

Observation:

  • A 2-year-old child experienced severe neurological symptoms, including status epilepticus and loss of consciousness, initially treated as a central nervous system infection.
  • Serological confirmation of Bartonella henselae infection prompted a shift to targeted antibiotic therapy.

Findings:

  • The patient's neurological symptoms improved with targeted antibiotic treatment.
  • Recurrence of seizures after initial treatment necessitated reintroduction of antiepileptics and antibiotics, indicating the complexity of managing neurological CSD.
  • A combination regimen of azithromycin and rifampin was ultimately effective in achieving recovery.

Implications:

  • This case underscores the importance of considering Bartonella henselae in pediatric neurological emergencies.
  • The successful use of azithromycin and rifampin provides valuable insights into antibiotic strategies for atypical CSD with neurological involvement.
  • Further research into optimal treatment durations and regimens for pediatric neurological CSD is warranted.
Abstract

Related Concept Videos